Articles tagged with “risk-sharing-agreements”

Value-Based Contracting in Pharma: A Guide to How It Works

Updated May 2026. Learn about value-based contracting (VBC) in pharma, including the CMS Cell and Gene Therapy Access Model, IRA negotiated prices, and outcomes-based agreements for Casgevy, Lyfgenia, Beqvez, and Roctavian.

55 min read

1/10/2026

value-based contracting outcomes-based agreements drug reimbursement pharmaceutical industry health economics real world evidence risk-sharing agreements pharma market access

Outcomes-Based Contracts: IT & Data Challenges Explained

Outcomes-based drug contracts and the IT/data infrastructure needed to track real-world patient outcomes. Updated April 2026 with CMS Multiple Best Prices, CGT Access Model, and IRA impacts.

55 min read

1/8/2026

outcomes-based contracts value-based care drug reimbursement health informatics real-world evidence healthcare data risk-sharing agreements

Value-Based Contracting in Pharma: Models & Challenges

An overview of value-based contracting (VBC) in pharmaceuticals, where drug prices are tied to patient outcomes. Covers models, challenges, case studies, CMS CGT Access Model (2025), finalized VBP rule (2026), and IRA drug price negotiations.

65 min read

10/13/2025

value-based contracting outcomes-based contracting pharmaceutical pricing drug reimbursement risk sharing agreements specialty pharma real-world evidence healthcare payers